Oxidation of caffeine to theobromine and theophylline is catalyzed primarily by flavin-containing monooxygenase in liver microsomes

被引:46
作者
Chung, WG
Cha, YN
机构
[1] INHA UNIV,COLL MED,DEPT PHARMACOL,INCHON 402751,SOUTH KOREA
[2] INHA UNIV,COLL MED,MED TOXICOL RES CTR,INCHON 402751,SOUTH KOREA
关键词
D O I
10.1006/bbrc.1997.6866
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Upon N-demethylation of caffeine (CA) by rat and human liver microsomes, theobromine (TB), paraxanthine (PX), and theophylline (TP) are produced. The optimal pHs for the formation of TB, PX, and TP from CA by rat liver microsomes are 7.4 (most), 8.2 (minor) and 8.6 (moderate). At pH 7.4, PX is the primary metabolite formed and makes up 48 % of the CA metabolites generated. In the presence of SKF525A, an inhibitor of P450 (CYP), the rates of TB, PX and TP production are inhibited by 32 %, 68 % and 42 %, respectively. Alternatively, in the presence of methimazole, an inhibitor of flavin-containing monooxygenase (FMO), the rates of TB, PX and TP production are inhibited by 66 %, 48 % and 73 %, respectively. In the presence of both SKF525A and methimazole, they are inhibited by 95 %, 84 % and 94 %, respectively. With human liver microsomes, the CA is metabolized faster but is inhibited more extensively either by SKF525A (PX production) or by methimazole (TB production). Alternatively, when CA is metabolized at pH 8.6, the optimal pH of FMO catalyzed reaction, the rates of TB and TP formation are increased but the rate of PX production is decreased. Furthermore, at pH 8.6 and in the presence of methimazole, the rates of TB and TP formation are decreased by 82 % and 95 %, respectively. These results indicate that the FMO is responsible primarily for productions of TB and TP and the CYP for PX. (C) 1997 Academic Press.
引用
收藏
页码:685 / 688
页数:4
相关论文
共 15 条
[1]  
[Anonymous], ENZYMATIC BASIS DETO
[2]   HUMAN CYTOCHROME P-450PA (P-450IA2), THE PHENACETIN O-DEETHYLASE, IS PRIMARILY RESPONSIBLE FOR THE HEPATIC 3-DEMETHYLATION OF CAFFEINE AND N-OXIDATION OF CARCINOGENIC ARYLAMINES - (AROMATIC-AMINES HETEROCYCLIC AMINES CARCINOGEN METABOLISM) [J].
BUTLER, MA ;
IWASAKI, M ;
GUENGERICH, FP ;
KADLUBAR, FF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :7696-7700
[3]   DETERMINATION OF CYP1A2 AND NAT2 PHENOTYPES IN HUMAN-POPULATIONS BY ANALYSIS OF CAFFEINE URINARY METABOLITES [J].
BUTLER, MA ;
LANG, NP ;
YOUNG, JF ;
CAPORASO, NE ;
VINEIS, P ;
HAYES, RB ;
TEITEL, CH ;
MASSENGILL, JP ;
LAWSEN, MF ;
KADLUBAR, FF .
PHARMACOGENETICS, 1992, 2 (03) :116-127
[4]  
CHUNG WG, 1994, TOXICOL APPL PHARM, V27, P314
[5]   AN ASSAY OF FLAVIN-CONTAINING MONOOXYGENASE ACTIVITY WITH BENZYDAMINE N-OXIDATION [J].
KAWAJI, A ;
OHARA, K ;
TAKABATAKE, E .
ANALYTICAL BIOCHEMISTRY, 1993, 214 (02) :409-412
[6]   STEREOSPECIFICITY IN THE OXIDATION OF PHORATE AND PHORATE SULFOXIDE BY PURIFIED FAD-CONTAINING MONO-OXYGENASE AND CYTOCHROME-P-450 ISOZYMES [J].
LEVI, PE ;
HODGSON, E .
XENOBIOTICA, 1988, 18 (01) :29-39
[7]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[8]  
NAKAJIMA M, 1994, CANCER EPIDEM BIOMAR, V3, P413
[9]  
OMURA T, 1964, J BIOL CHEM, V239, P2370
[10]  
ROSTAMIHODJEGAN A, 1997, PHARMACOGENETICS, V6, P121